Report predicts growth in U.S. SPECT and PET

07/30/2013 | (free registration)

The U.S. market for radiopharmaceuticals and devices looks promising, thanks to emerging agents, according to a Bio-Tech Systems report. The report predicts growth in PET sales of more than 20% in 2013, fueled in part by new imaging agents for Alzheimer's disease. Sales may grow to $4.7 billion by 2021, the report found. SPECT sales growth is estimated at 6% this year, and sales could reach $1.7 billion by 2021. "This will stimulate more research and investment, adding strength and stability to venture companies, as well as those more established in the field," according to the authors of the report.

View Full Article in: (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC